Literature DB >> 8632796

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.

J C Erickson1, K E Clegg, R D Palmiter.   

Abstract

Neuropeptide Y (NPY), a 36-amino-acid transmitter distributed throughout the nervous system, is thought to function as a central stimulator of feeding behaviour. NPY has also been implicated in the modulation of mood, cerebrocortical excitability, hypothalamic-pituitary signalling, cardiovascular physiology and sympathetic function. However, the biological significance of NPY has been difficult to establish owing to a lack of pharmacological antagonists. We report here that mice deficient for NPY have normal food intake and body weight, and become hyperphagic following food deprivation. Mutant mice decrease their food intake and lose weight, initially to a greater extent than controls, when treated with recombinant leptin. Occasional, mild seizures occur in NPY-deficient mice and mutants are more susceptible to seizures induced by a GABA (gamma-aminobutyric acid) antagonist. These results indicate that NPY is not essential for certain feeding responses or leptin actions but is an important modulator of excitability in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632796     DOI: 10.1038/381415a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  173 in total

1.  Short-term treatment with estrone oleate in liposomes (Merlin-2) does not affect the expression of the ob gene in Zucker obese rats.

Authors:  C Adán; M M Grasa; C Cabot; M Esteve; R Vilà; R Masanés; J Estruch; J A Fernández-López; X Remesar; M Alemany
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

Review 2.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 3.  Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice.

Authors:  G Kunos; S Bátkai
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 4.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

5.  Target-specific neuropeptide Y-ergic synaptic inhibition and its network consequences within the mammalian thalamus.

Authors:  Qian-Quan Sun; Scott C Baraban; David A Prince; John R Huguenard
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

6.  Capricious Cre: the devil is in the details.

Authors:  Christopher D Morrison; Heike Münzberg
Journal:  Endocrinology       Date:  2012-03       Impact factor: 4.736

7.  Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli.

Authors:  P Szot; D Weinshenker; S S White; C A Robbins; N C Rust; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

8.  Hypothalamic agouti-related peptide neurons and the central melanocortin system are crucial mediators of leptin's antidiabetic actions.

Authors:  Gabriel H M Gonçalves; Wenjing Li; Adriana V C-G Garcia; Mariana S Figueiredo; Christian Bjørbæk
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

9.  Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP.

Authors:  Michael J Krashes; Bhavik P Shah; Shuichi Koda; Bradford B Lowell
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

10.  Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

Authors:  Elizabeth M Powell; Daniel B Campbell; Gregg D Stanwood; Caleb Davis; Jeffrey L Noebels; Pat Levitt
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.